Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $5.8350 (25.62%) ($5.8350 - $5.8600) on Fri. Aug. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.58% (three month average) | RSI | 80 | Latest Price | $5.8350(25.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 11.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 26.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XLU(72%) ACES(69%) LIT(68%) ICLN(65%) XLRE(56%) | Factors Impacting ATRA price | ATRA will decline at least -5.29% in a week (0% probabilities). XOP(7%) OIH(8%) EDOC(9%) TBT(-22%) UUP(-23%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.29% (StdDev 10.58%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.76(22.58%) | 10 Day Moving Average | $4.02(45.15%) | 20 Day Moving Average | $3.7(57.7%) | To recent high | -33.5% | To recent low | 104.4% | Market Cap | $434m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |